1. Home
  2. ORIC vs HKD Comparison

ORIC vs HKD Comparison

Compare ORIC & HKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • HKD
  • Stock Information
  • Founded
  • ORIC 2014
  • HKD 2003
  • Country
  • ORIC United States
  • HKD France
  • Employees
  • ORIC N/A
  • HKD N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • HKD Finance: Consumer Services
  • Sector
  • ORIC Health Care
  • HKD Finance
  • Exchange
  • ORIC Nasdaq
  • HKD Nasdaq
  • Market Cap
  • ORIC 362.9M
  • HKD 656.8M
  • IPO Year
  • ORIC 2020
  • HKD 2022
  • Fundamental
  • Price
  • ORIC $10.85
  • HKD $1.77
  • Analyst Decision
  • ORIC Strong Buy
  • HKD
  • Analyst Count
  • ORIC 9
  • HKD 0
  • Target Price
  • ORIC $18.29
  • HKD N/A
  • AVG Volume (30 Days)
  • ORIC 932.0K
  • HKD 250.3K
  • Earning Date
  • ORIC 08-11-2025
  • HKD 01-01-0001
  • Dividend Yield
  • ORIC N/A
  • HKD N/A
  • EPS Growth
  • ORIC N/A
  • HKD 9.93
  • EPS
  • ORIC N/A
  • HKD 0.23
  • Revenue
  • ORIC N/A
  • HKD $20,445,000.00
  • Revenue This Year
  • ORIC N/A
  • HKD N/A
  • Revenue Next Year
  • ORIC N/A
  • HKD N/A
  • P/E Ratio
  • ORIC N/A
  • HKD $7.68
  • Revenue Growth
  • ORIC N/A
  • HKD N/A
  • 52 Week Low
  • ORIC $3.90
  • HKD $1.65
  • 52 Week High
  • ORIC $14.67
  • HKD $5.80
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 61.82
  • HKD 44.88
  • Support Level
  • ORIC $10.72
  • HKD $1.72
  • Resistance Level
  • ORIC $11.45
  • HKD $1.84
  • Average True Range (ATR)
  • ORIC 0.58
  • HKD 0.07
  • MACD
  • ORIC -0.08
  • HKD 0.01
  • Stochastic Oscillator
  • ORIC 57.65
  • HKD 48.33

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About HKD AMTD Digital Inc. (every five of which represent two)

AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment, hotel operations, hospitality and VIP services segment and media and entertainment services. The company generates maximum revenue by providing financial digital solutions through its insurance brokerage services and other digital solutions services. Geographically, the company generates maximum revenue from Hong Kong and Singapore.

Share on Social Networks: